Kinetic properties of GABA ρ1 homomeric receptors expressed in HEK293 cells

被引:11
|
作者
Yang, Jay [1 ]
Cheng, Qing [1 ]
Takahashi, Ayako [1 ]
Goubaeva, Farida [1 ]
机构
[1] Columbia Univ, Coll Phys & Surg, Dept Anesthesiol, New York, NY 10032 USA
关键词
D O I
10.1529/biophysj.106.085431
中图分类号
Q6 [生物物理学];
学科分类号
071011 ;
摘要
The rho 1 subunit of the ionotropic GABA receptors is thought to contribute to the formation of the GABA(C) receptors with pharmacological and physiological properties distinct from those of GABA(A) receptors. Previous characterization of this subunit expressed in the Xenopus oocytes revealed an ion channel with slow activation and deactivation and no desensitization, quite different from the properties of GABAC receptors observed in native cells. We expressed the human rho 1 subunit in human embryonic kidney (HEK) 293 cells and quantitatively characterized the kinetic properties of these receptors using a rapid drug application device. The rho 1 subunit expressed in HEK293 cells exhibited pharmacological and kinetic properties qualitatively identical to those described when rho 1 was expressed in the oocytes. An apparent desensitizing current observed during a constant GABA application was determined to be secondary to an E-Cl shift. Detailed kinetic analyses and parameter estimation for a five-state kinetic model revealed that the channel is best described by a set of rate constants with a notably faster GABA unbinding K-off rate compared to the parameters proposed for the same subunit expressed in the oocytes. The same subunit expressed in hippocampal neurons showed activation and deactivation kinetics identical to the current characterized in HEK293 cells. The kinetic properties of rho 1 subunit expressed in a nonoocyte model system may be better described quantitatively by the rate constants presented here.
引用
收藏
页码:2155 / 2162
页数:8
相关论文
共 50 条
  • [21] Activation by forskolin of the organic cation transporter ROCT1 expressed in HEK293 cells
    Hohage, I
    Lelleck, S
    Stachon, A
    Haxelmans, S
    Koepsell, H
    Schlatter, E
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1998, 358 (01) : R741 - R741
  • [22] Polyamines block rat skeletal muscle (μ1) sodium channels expressed in HEK293 cells
    Huang, CJ
    Moczydlowski, E
    JOURNAL OF GENERAL PHYSIOLOGY, 2000, 116 (01): : 12A - 12A
  • [23] Xanthine drug activation of CFTR channels expressed in HEK293 cells.
    Arispe, N
    Ma, J
    Pollard, H
    BIOPHYSICAL JOURNAL, 1997, 72 (02) : TUAM9 - TUAM9
  • [24] Allocryptopine and benzyltetrahydropalmatine block hERG potassium channels expressed in HEK293 cells
    Lin, Kun
    Liu, Yu-qi
    Xu, Bin
    Gao, Jin-liao
    Fu, Yi-cheng
    Chen, Yu
    Xue, Qiao
    Li, Yang
    ACTA PHARMACOLOGICA SINICA, 2013, 34 (06) : 847 - 858
  • [25] NGD 94-1 as an agonist at human recombinant dopamine D4.4 receptors expressed in HEK293 cells
    Gazi, L
    Sommer, B
    Nozulak, J
    Schoeffter, P
    EUROPEAN JOURNAL OF PHARMACOLOGY, 1999, 372 (03) : R9 - R10
  • [26] Recombinant α1β2γ2 GABAA receptors expressed in HEK293 and in QT6 cells show different kinetics
    Mercik, K
    Pytel, M
    Mozrzymas, JW
    NEUROSCIENCE LETTERS, 2003, 352 (03) : 195 - 198
  • [27] Inhibitory effects and mechanism of dihydroberberine on hERG channels expressed in HEK293 cells
    Yu, Dahai
    Lv, Lin
    Fang, Li
    Zhang, Bo
    Wang, Junnan
    Zhan, Ge
    Zhao, Lei
    Zhao, Xin
    Li, Baoxin
    PLOS ONE, 2017, 12 (08):
  • [28] Purification and characterization of the creatine transporter expressed at high levels in HEK293 cells
    West, M
    Park, D
    Dodd, JR
    Kistler, J
    Christie, DL
    PROTEIN EXPRESSION AND PURIFICATION, 2005, 41 (02) : 393 - 401
  • [29] Functional characterization of phosphodiesterase/nucleotide pyrophosphatase I expressed in HEK293 cells
    Matsuoka, I
    JAPANESE JOURNAL OF PHARMACOLOGY, 2002, 88 : 148P - 148P
  • [30] Etomidate Effects on Desensitization and Deactivation of α4β3δ GABAA Receptors Inducibly Expressed in HEK293 TetR Cells
    Liao, Yiwei
    Liu, Xiang
    Jounaidi, Youssef
    Forman, Stuart A.
    Feng, Hua-Jun
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2019, 368 (01): : 100 - 105